Therapeutic proteins immunogenicity: a peptide point of view
Protein therapeutics are extensively used in the treatment of autoimmune diseases, but a subset of patients appears to be refractory to these treatments, mainly due to the development of an immune response to the drug. A better understanding of the mechanism underlying the therapeutic drug’s failure...
Saved in:
Main Authors: | Feliciana Real-Fernandez, Fosca Errante, Andrea Di Santo, Anna Maria Papini, Paolo Rovero |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration
2023-10-01
|
Series: | Exploration of Drug Science |
Subjects: | |
Online Access: | https://www.explorationpub.com/uploads/Article/A100825/100825.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synthetic peptides as valuable and versatile tools for research: our 20 year journey in Chile
by: Constanza Cárdenas, et al.
Published: (2024-10-01) -
Nature-inspired and medicinally relevant short peptides
by: Maria G. Ciulla, et al.
Published: (2023-06-01) -
Late-stage diversification strategy for the synthesis of peptide acids and amides using hydrazides
by: Shoko Tanaka, et al.
Published: (2023-10-01) -
Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01) -
21st century Latin American synthetic peptides for their application in antivenom production
by: Jésica A. Rodríguez, et al.
Published: (2024-09-01)